MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grünewald, S.
Right arrow Articles by Köhr, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grünewald, S.
Right arrow Articles by Köhr, G.

Vol. 61, Issue 5, 1070-1080, May 2002

Importance of the gamma -Aminobutyric AcidB Receptor C-Termini for G-Protein Coupling

Sylvia Grünewald, Bettina J. Schupp, Stephen R. Ikeda,1 Rohini Kuner,2 Frank Steigerwald,3 Hans-Christian Kornau,4 and Georg Köhr

Axaron Bioscience AG, Heidelberg, Germany (S.G., R.K., H.-C.K.); Department of Molecular Neurobiology, Max-Planck-Institute for Medical Research, Heidelberg, Germany (B.J.S., G.K., F.S.); Laboratory of Molecular Physiology, Guthrie Research Institute, Sayre, Pennsylvania (S.R.I.)

Functional gamma -aminobutyric acidB (GABAB) receptors assemble from two subunits, GABAB(1) and GABAB(2). This heteromerization, which involves a C-terminal coiled-coil interaction, ensures efficient surface trafficking and agonist-dependent G-protein activation. In the present study, we took a closer look at the implications of the intracellular C termini of GABAB(1) and GABAB(2) for G-protein coupling. We generated a series of C-terminal mutants of GABAB(1) and GABAB(2) and tested them for physical interaction, surface trafficking, coupling to adenylyl cyclase, and G-protein-gated inwardly rectifying potassium channels in human embryonic kidney (HEK) 293 cells as well as on endogenous calcium channels in sympathetic neurons of the superior cervical ganglion (SCG). We found that the C-terminal interaction contributes only partly to the heterodimeric assembly of the subunits, indicating the presence of an additional interaction site. The described endoplasmic reticulum retention signal within the C terminus of GABAB(1) functioned only in the context of specific amino acids, which constitute part of the GABAB(1) coiled-coil sequence. This finding may provide a link between the retention signal and its shielding by the coiled coil of GABAB(2). In HEK293 cells, we observed that the two well-known GABAB receptor antagonists [S-(R*,R*)]-[3-[[1-(3,4-dichlorophenyl)ethyl]amino]-2-hydroxypropyl](cyclohexylmethyl) phosphinic acid (CGP54626) and (+)-(2S)-5,5-dimethyl-2-morpholineacetic acid (SCH50911) CGP54626 and SCH50911 function as inverse agonists. The C termini of GABAB(1) and GABAB(2) strongly influenced agonist-independent G-protein coupling, although they were not necessary for agonist-dependent G-protein coupling. The C-terminal GABAB receptor mutants described here demonstrate that the active receptor conformation is stabilized by the coiled-coil interaction. Thus, the C-terminal conformation of the GABAB receptor may determine its constitutive activity, which could be a therapeutic target for inverse agonists.


1 Current address: National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland.

2 Current address: Department of Molecular Pharmacology, University of Heidelberg, Heidelberg, Germany.

3 Current address: Department of Physiology, University of Kiel, Kiel, Germany.

4 Current address: Center for Molecular Neurobiology (ZMNH), University of Hamburg, Hamburg, Germany.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. M. Pooler and R. A. J. McIlhinney
Lateral Diffusion of the GABAB Receptor Is Regulated by the GABAB2 C Terminus
J. Biol. Chem., August 31, 2007; 282(35): 25349 - 25356.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. S. Mukherjee, E. W. McBride, M. Beinborn, K. Dunlap, and A. S. Kopin
Point Mutations in Either Subunit of the GABAB Receptor Confer Constitutive Activity to the Heterodimer
Mol. Pharmacol., October 1, 2006; 70(4): 1406 - 1413.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
M. W. Fleck
Glutamate Receptors and Endoplasmic Reticulum Quality Control: Looking beneath the Surface
Neuroscientist, June 1, 2006; 12(3): 232 - 244.
[Abstract] [PDF]


Home page
Exp. Biol. Med.Home page
X. Dai and J. J. Galligan
Differential Trafficking and Desensitization of Human ETA and ETB Receptors Expressed in HEK 293 Cells.
Experimental Biology and Medicine, June 1, 2006; 231(6): 746 - 751.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Gassmann, C. Haller, Y. Stoll, S. A. Aziz, B. Biermann, J. Mosbacher, K. Kaupmann, and B. Bettler
The RXR-Type Endoplasmic Reticulum-Retention/Retrieval Signal of GABAB1 Requires Distant Spacing from the Membrane to Function
Mol. Pharmacol., July 1, 2005; 68(1): 137 - 144.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. J. Mah, E. Cornell, N. A. Mitchell, and M. W. Fleck
Glutamate Receptor Trafficking: Endoplasmic Reticulum Quality Control Involves Ligand Binding and Receptor Function
J. Neurosci., March 2, 2005; 25(9): 2215 - 2225.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Kanki, S. Kupershmidt, T. Yang, S. Wells, and D. M. Roden
A Structural Requirement for Processing the Cardiac K+ Channel KCNQ1
J. Biol. Chem., August 6, 2004; 279(32): 33976 - 33983.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Binet, C. Brajon, L. Le Corre, F. Acher, J.-P. Pin, and L. Prezeau
The Heptahelical Domain of GABAB2 Is Activated Directly by CGP7930, a Positive Allosteric Modulator of the GABAB Receptor
J. Biol. Chem., July 9, 2004; 279(28): 29085 - 29091.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. Bettler, K. Kaupmann, J. Mosbacher, and M. Gassmann
Molecular Structure and Physiological Functions of GABAB Receptors
Physiol Rev, July 1, 2004; 84(3): 835 - 867.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. A. Syme, K. L. Hamilton, H. M. Jones, A. C. Gerlach, L. Giltinan, G. D. Papworth, S. C. Watkins, N. A. Bradbury, and D. C. Devor
Trafficking of the Ca2+-activated K+ Channel, hIK1, Is Dependent upon a C-terminal Leucine Zipper
J. Biol. Chem., February 28, 2003; 278(10): 8476 - 8486.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics